🔴 Nanox Imaging is trading 22.61% down in pre-market ahead of Q2 results amid liquidity concerns

Nanox Imaging is trading 22.61% down at $0.72 after opening below the September 8 close of $0.93, as investors focus on upcoming Q2 results and liquidity.

• Healthcare ETF XLV is down 2.52%, adding sector pressure.
• Nanox Imaging is scheduled to report Q2 2026 results before market open on September 9, with an 8:30 a.m. ET call.
• Preliminary figures indicated $4.0–$4.1 million revenue and approximately $31.4 million cash, increasing investor focus on liquidity.